Related Experiment Video
Updated: Apr 28, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Myocardial ischemic reperfusion induces de novo Nrf2 protein translation
Beibei Xu1, Jack Zhang1, Joshua Strom1
1Department of Pharmacology, College of Medicine, University of Arizona, 1501 N. Campbell Ave, Tucson, AZ 85724, USA.
Abstract:
Nrf2 is a bZIP transcription factor regulating the expression of antioxidant and detoxification genes. We have found that Nrf2 knockout mice have an increased infarction size in response to regional ischemic reperfusion and have a reduced degree of cardiac protection by means of ischemic preconditioning. With cycles of brief ischemia and reperfusion (5'I/5'R) that induce cardiac protection in wild type mice, an elevated Nrf2 protein was observed without prior increases of Nrf2 mRNA. When an mRNA species is being translated into a protein, it is occupied by multiple ribosomes. The level of ribosome-associated Nrf2 mRNA increased following cycles of 5'I/5'R, supporting de novo Nrf2 protein translation. A dicistronic reporter assay indicated a role of the 5' untranslated region (5' UTR) of Nrf2 mRNA in oxidative stress induced Nrf2 protein translation in isolated cardiomyocytes. Western blot analyses after isolation of proteins binding to biotinylated Nrf2 5' UTR from the myocardium or cultured cardiomyocytes demonstrated that cycles of 5'I/5'R or oxidants caused an increased association of La protein with Nrf2 5' UTR. Ribonucleoprotein complex immunoprecipitation assays confirmed such association indeed occurring in vivo. Knocking down La using siRNA was able to prevent Nrf2 protein elevation by oxidants in cultured cardiomyocytes and by cycles of 5'I/5'R in the myocardium. Our data point out a novel mechanism of cardiac protection by de novo Nrf2 protein translation involving interaction of La protein with 5' UTR of Nrf2 mRNA in cardiomyocytes.
Insights
Nuclear factor erythroid 2-related factor 2 (Nrf2) protein translation, not mRNA, drives cardiac protection. La protein binding to Nrf2 mRNA’s 5’ UTR enhances this protective translation during oxidative stress.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Gene Regulation
Background:
- Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key transcription factor for antioxidant and detoxification genes.
- Nrf2 deficiency exacerbates cardiac injury and impairs protection from ischemic preconditioning.
Purpose of the Study:
- To investigate the mechanism of Nrf2-mediated cardiac protection, focusing on protein translation regulation.
- To elucidate the role of the 5' untranslated region (5' UTR) of Nrf2 mRNA and associated proteins in this process.
Main Methods:
- Utilized Nrf2 knockout mice and ischemic preconditioning models.
- Analyzed ribosome-associated Nrf2 mRNA and performed dicistronic reporter assays.
- Investigated protein-RNA interactions using Western blot and ribonucleoprotein complex immunoprecipitation (RIP) assays.
- Employed siRNA to knockdown La protein.
Main Results:
- Ischemic preconditioning elevated Nrf2 protein without increasing Nrf2 mRNA, suggesting post-transcriptional regulation.
- Ribosome-associated Nrf2 mRNA levels increased, supporting de novo translation.
- La protein binding to the Nrf2 mRNA 5' UTR was enhanced by oxidative stress and ischemic preconditioning.
- Knockdown of La protein abolished Nrf2 protein elevation, preventing cardiac protection.
Conclusions:
- Cardiac protection involves de novo Nrf2 protein translation, regulated by the La protein interaction with the Nrf2 mRNA 5' UTR.
- This mechanism highlights a novel pathway for Nrf2-mediated cardioprotection under stress conditions.
Related Concept Videos
Regulation of the Unfolded Protein Response
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The Unfolded Protein Response
Myocarditis I: Introduction

